167 related articles for article (PubMed ID: 10637966)
1. [Anti-TNF-alpha therapy as a new option in treatment of rheumatoid arthritis?].
Leeb BF; Sautner J
Wien Med Wochenschr; 1999; 149(19-20):554-7. PubMed ID: 10637966
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Tijhuis GJ; van de Putte LB; Breedveld FC
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
[TBL] [Abstract][Full Text] [Related]
3. [TNF alpha-antagonists in collagen vascular disease].
Manger K; Manger B
Z Rheumatol; 2003 Jun; 62(3):240-5. PubMed ID: 12827400
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome.
Jit M; Henderson B; Stevens M; Seymour RM
Rheumatology (Oxford); 2005 Mar; 44(3):323-31. PubMed ID: 15585509
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
Moreland LW
Isr Med Assoc J; 2001 Sep; 3(9):686-90. PubMed ID: 11574988
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Jones RE; Moreland LW
Bull Rheum Dis; 1999; 48(3):1-4. PubMed ID: 10408141
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF-alpha-induced systemic lupus syndrome.
Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
10. Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.
Ferraccioli G; Gremese E
Autoimmun Rev; 2004 Jun; 3(4):261-6. PubMed ID: 15246021
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
Baumgartner SW
South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
[TBL] [Abstract][Full Text] [Related]
12. Biologics in rheumatoid arthritis.
Sharma PK; Hota D; Pandhi P
J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNFalpha therapy for rheumatoid arthritis: an update.
Taylor PC
Intern Med; 2003 Jan; 42(1):15-20. PubMed ID: 12583612
[TBL] [Abstract][Full Text] [Related]
14. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.
Wolfe F; Michaud K
Am J Med; 2004 Mar; 116(5):305-11. PubMed ID: 14984815
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
Guillevin L; Mouthon L
J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
[No Abstract] [Full Text] [Related]
16. [Rheumatoid arthritis: current status of therapy].
El Bahri DM; Meddeb N; Sellami S
Tunis Med; 2007 Jan; 85(1):1-8. PubMed ID: 17424701
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring of clinical course in TNF inhibitor treatment for rheumatoid arthritis--efficacy evaluation, adverse effect detection, and prediction of clinical response].
Yamamura M
Nihon Rinsho; 2007 Jul; 65(7):1269-75. PubMed ID: 17642242
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
19. Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S; Fatima F; Moots RJ
Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
[No Abstract] [Full Text] [Related]
20. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
Tanaka Y
Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
